Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies
Despite important advances in the treatment of metastatic melanoma with the development of MAPK-targeted agents and immune checkpoint inhibitors, the majority of patients either do not respond to therapies or develop acquired resistance. Furthermore, there is no effective targeted therapy currently...
Gardado en:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2023-07-01
|
| Series: | Cells |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/2073-4409/12/14/1855 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|